"Sorry for the extreme ignorance but how does good Keytruda news help us?"
In my opinion the more valuable Keytruda is to Merck, and the more valuable Yervoy is to BristolMS, the better it is for VLA. Because more and more evidence is coming out saying that their drugs are better and safer with Cavatak.
I like the fact that today we got news mentioning both.
As I said before, a partnership or takeover is worth doing for these big companies, not only to improve their product but to stop their competitors product being improved too.
VLA Price at posting:
91.0¢ Sentiment: Buy Disclosure: Held
